Literature DB >> 21881459

Memantine for comorbid obsessive-compulsive disorder and Asperger disorder suggests a link in glutamatergic dysregulation.

Erica B Bernhardt, Kelda H Walsh, David J Posey, Christopher J McDougle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21881459     DOI： 10.1097/JCP.0b013e31822c92d4

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  3 in total

Review 1.  The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review.

Authors:  Daniel A Rossignol; Richard E Frye
Journal:  Front Pediatr       Date:  2014-08-22       Impact factor: 3.418

2.  Efficacy of Memantine as Adjunct Therapy for Autism Spectrum Disorder in Children Aged <14 Years.

Authors:  Mojgan Karahmadi; Mohammad Javad Tarrahi; Samaneh Sadat Vatankhah Ardestani; Victoria Omranifard; Behdad Farzaneh
Journal:  Adv Biomed Res       Date:  2018-10-01

Review 3.  Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.

Authors:  Carolyn A Doyle; Christopher J McDougle
Journal:  Dialogues Clin Neurosci       Date:  2012-09       Impact factor: 5.986
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.